Penbrook Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $987K | Buy |
1,694
+797
| +89% | +$465K | 0.37% | 58 |
|
|
2025
Q1 | $569K | Hold |
897
| – | – | 0.43% | 52 |
|
|
2024
Q4 | $639K | Sell |
897
-250
| -22% | -$178K | 0.44% | 49 |
|
|
2024
Q3 | $1.21M | Hold |
1,147
| – | – | 0.78% | 28 |
|
|
2024
Q2 | $1.21M | Hold |
1,147
| – | – | 0.74% | 28 |
|
|
2024
Q1 | $1.1M | Hold |
1,147
| – | – | 0.68% | 32 |
|
|
2023
Q4 | $1.01M | Buy |
1,147
+100
| +10% | +$87.8K | 0.68% | 33 |
|
|
2023
Q3 | $862K | Buy |
1,047
+25
| +2% | +$20.6K | 0.63% | 38 |
|
|
2023
Q2 | $734K | Sell |
1,022
-50
| -5% | -$35.9K | 0.53% | 44 |
|
|
2023
Q1 | $881K | Hold |
1,072
| – | – | 0.67% | 41 |
|
|
2022
Q4 | $773K | Sell |
1,072
-200
| -16% | -$144K | 0.66% | 43 |
|
|
2022
Q3 | $876K | Hold |
1,272
| – | – | 0.75% | 36 |
|
|
2022
Q2 | $752K | Hold |
1,272
| – | – | 0.59% | 51 |
|
|
2022
Q1 | $888K | Hold |
1,272
| – | – | 0.58% | 54 |
|
|
2021
Q4 | $803K | Hold |
1,272
| – | – | 0.48% | 62 |
|
|
2021
Q3 | $770K | Hold |
1,272
| – | – | 0.48% | 64 |
|
|
2021
Q2 | $710K | Buy |
1,272
+462
| +57% | +$258K | 0.43% | 65 |
|
|
2021
Q1 | $383K | Buy |
+810
| New | +$383K | 0.28% | 82 |
|